Expert opinion on pharmacotherapyHumansUrinary Tract InfectionsAnti-Bacterial AgentsCefepimebeta-Lactamase Inhibitors
Investigating cefepime/taniborbactam for the treatment of complicated urinary tract infections.
Claudia Bartalucci, Marianna Giurco, Antonio Vena, Daniele Roberto Giacobbe, Matteo Bassetti
Published: 202510.1080/14656566.2025.2574849
Abstract
INTRODUCTION: The spread of multidrug-resistant (MDR) Gram-negative bacteria, such as carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa, has led to a pressing need for novel treatment options. Cefepime/taniborbactam is a new β-lactam/β…
Preview only. Read the full abstract at the source